ACLARION, INC. Allowance for Doubtful Accounts, Premiums and Other Receivables
ACLARION, INC. (ACON) had Allowance for Doubtful Accounts, Premiums and Other Receivables of $6.36 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables · last filed 2026-08-06
- 2026-06-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $6.36K.
- 2026-03-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $11.91K.
- 2025-12-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $6.24K.
- 2024-12-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $0.00.
| Period end | Allowance for Doubtful Accounts, Premiums and Other Receivables |
|---|---|
| 2026-06-30 | $6.36K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $11.91K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $6.24K 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 |
| 2023-12-31 | $0.00 10-K · filed 2025-04-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |